166 related articles for article (PubMed ID: 10408406)
1. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.
Widel M; Jedruś S; Owczarek S; Konopacka M; Lubecka B; Kołosza Z
Br J Cancer; 1999 Jul; 80(10):1599-607. PubMed ID: 10408406
[TBL] [Abstract][Full Text] [Related]
2. Micronucleus assay in vivo provides significant prognostic information in human cervical carcinoma; the updated analysis.
Widel M; Kolosza Z; Jedruś S; Lukaszczyk B; Raczek-Zwierzycka K; Swierniak A
Int J Radiat Biol; 2001 May; 77(5):631-6. PubMed ID: 11382342
[TBL] [Abstract][Full Text] [Related]
3. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
Jeremić B; Sibamoto J; Abe M
Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
Shibamoto Y; Ike O; Mizuno H; Fukuse T; Hitomi S; Takahashi M
Clin Cancer Res; 1998 Mar; 4(3):677-82. PubMed ID: 9533537
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy induced micronuclei in cervical cancer--does it have a predictive value for local disease control?
Singh S; Datta NR; Krishnani N; Lal P; Kumar S
Gynecol Oncol; 2005 Jun; 97(3):764-71. PubMed ID: 15943985
[TBL] [Abstract][Full Text] [Related]
6. The radiosensitivity of human malignant melanomas evaluated by cytokinesis-block micronucleus assay.
Wideł M; Dobrut M; Maka B; Lubecka B; Pluciennik A
Neoplasma; 1997; 44(2):109-16. PubMed ID: 9201290
[TBL] [Abstract][Full Text] [Related]
7. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
8. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Fuhrmann C; Budach V
Radiat Res; 1991 Dec; 128(3):293-300. PubMed ID: 1961926
[TBL] [Abstract][Full Text] [Related]
9. Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Dec; 39(12):2077-9. PubMed ID: 9867144
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients.
Bhosle SM; Huilgol NG; Mishra KP
Cancer Detect Prev; 2005; 29(4):369-75. PubMed ID: 16125335
[TBL] [Abstract][Full Text] [Related]
11. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
[TBL] [Abstract][Full Text] [Related]
12. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
13. Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy.
Banerjee B; Sharma S; Hegde S; Hande MP
Breast Cancer Res Treat; 2008 Jan; 107(1):25-31. PubMed ID: 17333339
[TBL] [Abstract][Full Text] [Related]
14. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.
Cooper RA; West CM; Wilks DP; Logue JP; Davidson SE; Roberts SA; Hunter RD
Br J Cancer; 1999 Sep; 81(2):354-8. PubMed ID: 10496365
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity of peripheral blood lymphocytes from healthy donors and cervical cancer patients; the correspondence of in vitro data with the clinical outcome.
Gabelova A; Farkasova T; Gurska S; Machackova Z; Lukacko P; Witkovsky V
Neoplasma; 2008; 55(3):182-91. PubMed ID: 18348650
[TBL] [Abstract][Full Text] [Related]
16. The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy.
Song EY; Rizvi SM; Qu CF; Raja C; Yuen J; Li Y; Morgenstern A; Apostolidis C; Allen BJ
Phys Med Biol; 2008 Jan; 53(2):319-28. PubMed ID: 18184988
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
19. Interfacial properties as predictors of radioresistance in cervical cancer.
Anand P; Huilgol N; Banerjee R
J Colloid Interface Sci; 2007 Oct; 314(1):63-70. PubMed ID: 17610888
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
